ArticleMolecular therapy. Oncology2026
Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.
Bárbara Bueloni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it